Enjoy 30% off select life science products with free shipping and giveaways with promo code: RESEARCH30 Offer ends October 2, 2020.
Streptozocin is used to induce Type 1 diabetes for medical research. It has been used for the treatment of malignant insulinoma It is used mainly in the treatment of pancreatic (islet-cell) tumors.
Treatment of pancreatic (islet-cell) tumors
|Alternate Names||N-(Methylnitrosocarbamoyl)-α-D-glucosamine; Streptozocin; STZ; 2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose|
|Application Notes||Streptozocin is used to induce Type 1 diabetes for medical research. It has been used for the treatment of malignant insulinoma It is used mainly in the treatment of pancreatic (islet-cell) tumors.|
|Base Catalog Number||100557|
|Beilstein Registry Number||2060675|
|Biochemical Physiological Actions||An N-nitroso-containing compound that acts as a nitric oxide donor in pancreatic islets; induces death of insulin-secreting cells, producing an animal model of diabetes. Potent DNA methylating agent that induces chromosomal breakage. Cytotoxic to neuroendocrine tumor cell lines that express the GLUT2 glucose transporter.|
|Extinction Coefficient||EmM(228 nm): 6.36 (ethanol)|
|Half Life||biological half-life in cell culture medium was shown to be approximately 19 minutes.|
|Melting Point||239Â° F (Decomposes) (NTP, 1992)|
|Molecular Weight||265.222 g/mol|
|Personal Protective Equipment||Eyeshields, full-face particle respirator type N100, Gloves, respirator cartridge, respirator filter|
|Purity||~75% α-anomer basis; ≥97%|
|Solubility||Soluble (NTP, 1992)|
|Typical Working Concentration||Has been used in intravenous injections in rats at a dose of 65 mg/kg body weight to induce diabetes (using cold 0.1 M citrate buffer pH 4.5). In rats and dogs, diabetes was induced using intravenous dosage of 50 mg/kg body weight (using 1-2% w/v solutions in saline buffered with citrate dextrose solution at pH 5.0).|